“We have seen a reduction in volume in Q2 as compared to Q1 because there was a significant pre-buy in Q1 that happened because of the CPCB4 norm change. And because of that volume reduction, we have the operating leverage not kicking in and therefore a knock on margins per se in Q2. At the half year level though, we are well on track.”